Skip to main content
HUONS CO., LTD. logo

HUONS CO., LTD. — Investor Relations & Filings

Ticker · 243070 ISIN · KR7243070000 KO Manufacturing
Filings indexed 384 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country KR South Korea
Listing KO 243070

About HUONS CO., LTD.

https://www.huons.com/en

HUONS CO., LTD. is an integrated pharmaceutical and healthcare company founded in 1965. The company develops and manufactures a wide range of finished pharmaceutical products, medical solutions, and medical devices under cGMP standards. It was a pioneer in its domestic market, developing the first plastic ampule injections and local anesthetics. The company's research and development efforts focus on key therapeutic areas including ophthalmology, osteoarthritis, dermatology, wellness, and Central Nervous System (CNS) disorders. Its diversified portfolio also extends to bio products, eye drops, cosmetics, and health functional foods, aiming to provide comprehensive healthcare solutions.

Recent filings

Filing Released Lang Actions
주권매매거래정지해제 (우회상장 미해당)
Regulatory Filings Classification · 75% confidence The document is a short regulatory announcement notifying the market of the lifting of a trading suspension for the company’s common stock under KOSDAQ rules. It does not present financial statements, a report, or voting results, nor is it an announcement of a report publication. It is therefore classified as a general regulatory filing.
2026-05-18 Korean
주권매매거래정지 (우회상장여부 및 요건충족확인)
Regulatory Filings Classification · 80% confidence The text is a formal notice of share trading suspension (“주권매매거래정지”) under KOSDAQ market rules, citing regulatory provisions. It is a regulatory compliance announcement rather than a financial report, delisting confirmation, or management change. Hence, it falls under the generic Regulatory Filings category.
2026-05-18 Korean
주요사항보고서(회사합병결정)
M&A Activity Classification · 95% confidence The document is a mandatory corporate disclosure to the Korea Exchange and Financial Supervisory Service detailing the decision to merge two companies (주식회사 휴온스 and 주식회사 휴온스랩). It provides extensive information on the merger ratio, valuation methodology, timelines, shareholder rights (including appraisal rights), and regulatory references – all hallmarks of an M&A Activity announcement rather than a general notice or earnings report. Therefore, it falls squarely under the M&A Activity category.
2026-05-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 75% confidence The document is a regulatory announcement setting the shareholder register closure period and record date for determining voting rights for an upcoming shareholders meeting. It does not contain financial statements or meeting materials, nor is it the minutes or results of a vote. It fits the fallback category for general compliance/regulatory filings under ‘Regulatory Filings’ (RNS).
2026-05-18 Korean
주주총회소집결의 (임시주주총회)
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice convening an extraordinary general meeting (임시주주총회) including date, venue, record date, agenda items (merger approval, articles amendment), and business objective changes. It is sent to shareholders to inform them and solicit their votes. This fits the Proxy Solicitation & Information Statement category (PSI).
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled “분기보고서” and covers the period January 1, 2026 to March 31, 2026. It is filed with the Financial Services Commission and Korea Exchange, includes detailed financial statements and operational analysis for the quarter, and matches the definition of a comprehensive interim/quarterly report. Therefore, it is classified as an Interim / Quarterly Report. Q1 2026
2026-05-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.